Many biotechs traversing the "valley of death" experienced this period, for multiple years. To come through it and then to multiply by 100's of times is what we are all here for. TLX, RAC, PME, DXB, IMU, NEU ect ect they all did it.
They key is you don't have to hold on to any bio for a buyout, because they could easily go back into the death valley because they forgot a shoe there.
If you forget the CHM share price, and just look at the company itself, they were able to to secure and progress complex unique science from the lab to be delivering it into very sick people hoping to change their dire prognosis on living. That in itself goes beyond money. Money means nothing if you're dead. So we NEED to see that the company gets to the readouts at the end of the year and stop with the emotional P hopper crap that clogs these forums. He pulled the science together, raised the funds, listed the company on the ASX so others can invest in its success. He put an amazing team together to select and lift the assets off the ground. Now we are at a different stage, slightly more mature. So he made the hard decision to let our CEO go (speculating here; perhaps because we needed some new energy in the group or to control cost measures). He/Jen made sure IMU paid CHM a finders fee for what will be perhaps IMU's greatest asset in Azercel, while lining the hungry coffers of the CHM group. Speculating again, IMO Jennifer literally could be credited for any future success these two companies may have. However she did come with a hefty price tag, and when you are trading through a biotech winter, that sort of renumeration is not realistic especially when your companys EV is below your wage.
Now we have an ambitious (and more realistically compensated) new COO (soon to be new CEO) and that may be a brilliant move on behalf of PH and crew to take CHM out of the valley of death. She looks invigorated and determined. We need to trust the process or else they will fail, and that will be a fail to people who are dying. All we need to do is stop the emotional selling and allow this company to get to the end of 2024 in a healthy state for multiple catalyst events.
CHM Price at posting:
1.7¢ Sentiment: Hold Disclosure: Held
